Glenmark inks agreement with AstraZeneca to commercialise Pulmicort Respules in Colombia EP News Bureau Feb 15, 2022 As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules, and will manufacture the drug.…
